Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 12, 2005
Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic ratsGerd Luippold, Martina Beilharz, Manfred Wehrmann, et al.Translational Stroke Research|December 11, 2013
Evidence for a predominant intrinsic sympathetic control of cerebral blood flow alterations in an animal model of cerebral arteriovenous malformationCarsten Stüer, Toshiki Ikeda, Michael Stoffel, et al.International Journal of Molecular Sciences|May 7, 2016
Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty RatsDenis Delic, Claudia Eisele, Ramona Schmid, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 27, 2007
Arterial blood pressure and renal sodium excretion in dopamine D3 receptor knockout miceTorsten Staudacher, Bärbel Pech, Michael Tappe, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 24, 2004
Subapical localization of the dopamine D3 receptor in proximal tubules of the rat kidneyAsja Nürnberger, Marcus Räbiger, Andreas Mack, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|December 24, 2005
Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout miceGerd Luippold, Bärbel Pech, Swetlana Schneider, et al.Neurosurgery|October 1, 2008
Norepinephrine and cerebral blood flow regulation in patients with arteriovenous malformationsCarsten Stüer, Toshiki Ikeda, Michael Stoffel, et al.Journal of the American Society of Nephrology : JASN|October 25, 2001
Dopamine D(3) receptors and salt-dependent hypertensionGerd Luippold, Claudia Zimmermann, Matthias Mai, et al.Science Signaling|February 16, 2017
A high-throughput, image-based screen to identify kinases involved in brown adipocyte developmentAliki Perdikari, Elisabeth Kulenkampff, Carla Rudigier, et al.Journal of Biomolecular Screening|May 6, 2011
Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testingKarsten Suhre, Werner Römisch-Margl, Martin Hrabé de Angelis, et al.Pageof 3